Catalyst Pharmaceutical CPRX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Catalyst Pharmaceutical’s reported figures.
Based on trailing twelve months.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's asset turnover?
- Catalyst Pharmaceutical (CPRX) reported asset turnover of 0.6× in Q1 2026.
- How has Catalyst Pharmaceutical's asset turnover changed year-over-year?
- Catalyst Pharmaceutical's asset turnover decreased by 15.5% year-over-year, from 0.7× to 0.6×.
- What is the long-term trend for Catalyst Pharmaceutical's asset turnover?
- Over 5 years (2020 to 2025), Catalyst Pharmaceutical's asset turnover has grown at a -5.1% compound annual growth rate (CAGR), from 0.8× to 0.6×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.